Given the task definition and input, reply with output. In this task, you are given text for US Congressional and California state bills, your task is to generate a summary for this bill.

SECTION 1. SHORT TITLE; AMENDMENT REFERENCES.

(a) Short Title.--This Act may be cited as the ''Drug Czar
Responsibility and Accountability Act of 1998''.
(b) Amendment References.--Except as otherwise expressly provided,
whenever in this Act an amendment or repeal is expressed in terms of an
amendment to, or repeal of, a section or other provision, the reference
shall be considered to be made to a section or other provision of the
National Narcotics Leadership Act of 1988 (21 U.S.C. 1501 et seq.).

SEC. 2. FINDINGS.

Congress makes the following findings:
(1) Overall drug use among children aged 12 to 17 in 1992
was 5.3 percent. In 1996, it was 9 percent, an increase of 70
percent.
(2) Use of any illicit drug among 8th graders in 1992 was
12.9 percent. In 1997, it was 22.1 percent, an increase of 71
percent.
(3) Use of any illicit drug among 10th graders in 1992 was
20.4 percent. In 1997, it was 38.5 percent, an increase of 91
percent.
(4) Use of any illicit drug among 12th graders in 1992 was
27.1 percent. In 1997, it was 42.4 percent, an increase of 56
percent.
(5) Use of marijuana among 8th graders in 1992 was 3.7
percent. In 1997, it was 10.2 percent, an increase of 176
percent.
(6) Use of marijuana among children aged 12 to 17 in 1992
was 3.4 percent. In 1996, it was 7.1 percent, an increase of
109 percent.
(7) Use of cocaine among children aged 12 to 17 in 1992 was
0.3 percent. In 1996, it was 0.6 percent, an increase of 100
percent.
(8) Marijuana-related medical emergencies in 1992 totaled
23,997. In 1996, there were 50,037 such emergencies, an
increase of 108 percent.
(9) Cocaine-related medical emergencies in 1992 totaled
119,843. In 1996, there were 144,180 such emergencies, an
increase of 20 percent.
(10) Heroin-related medical emergencies in 1992 totaled
48,003. In 1996, there were 70,463 such emergencies, an
increase of 47 percent.

SEC. 3. EXPANSION OF RESPONSIBILITIES OF DIRECTOR.

(a) Expansion of Responsibilities.--Section 1003(b) (21 U.S.C.
1502(b)) is amended--
(1) by striking paragraph (1) and inserting the following:
''(1) establish Federal policies, objectives, goals,
priorities, and performance measures (including specific annual
agency targets expressed in terms of precise percentages) for
the National Drug Control Program and for each National Drug
Control Program agency, which shall include targets for
reducing the levels of overall unlawful drug use, adolescent
unlawful drug use, and drug-related emergency room incidents to
January 19, 1993 levels;'';
(2) by striking paragraph (3) and inserting the following:
''(3) coordinate, oversee, and evaluate the effectiveness
of the implementation of the policies, objectives, goals,
performance measures, and priorities established under
paragraph (1) and the fulfillment of the responsibilities of
the National Drug Control Program agencies under the National
Drug Control Strategy;'';
(3) in paragraph (5), by inserting ''and nongovernmental
entities involved in demand reduction'' after ''governments'';
(4) in paragraph (7), by striking ''and'' at the end;
(5) in paragraph (8), by striking the period at the end and
inserting a semicolon; and
(6) by adding at the end the following:
''(9) require each National Drug Control Program agency to
submit to the Director on a semi-annual basis (beginning with
the first 6 months of 1999) an evaluation of progress by the
agency with respect to drug control program goals using
the performance measures referred to in paragraph (1), including
progress with respect to--
''(A) success in reducing domestic and foreign
sources of illegal drugs;
''(B) success in protecting the borders of the
United States (and in particular the Southwestern
border of the United States) from penetration by
illegal narcotics;
''(C) success in reducing violent crime associated
with drug use in the United States;
''(D) success in reducing the negative health and
social consequences of drug use in the United States;
and
''(E) implementation of drug treatment and
prevention programs in the United States and
improvements in the adequacy and effectiveness of such
programs;
''(10) submit to Congress on a semiannual basis, not later
than 60 days after the date of the last day of the applicable
6-month period, a summary of--
''(A) each evaluation received by the Director
under paragraph (9); and
''(B) the progress of each National Drug Control
Program agency toward the drug control program goals of
the agency using the performance measures described in
paragraph (1);
''(11) require the National Drug Control Program agencies
to submit to the Director not later than February 1 of each
year a detailed accounting of all funds expended by the
agencies for National Drug Control Program activities during
the previous fiscal year, and require such accounting to be
authenticated by the Inspector General for each agency prior to
submission to the Director;
''(12) submit to Congress not later than April 1 of each
year the information submitted to the Director under paragraph
(11);
''(13) submit to Congress not later than August 1 of each
year a report including--
''(A) the budget guidance provided by the Director
to each National Drug Control Program agency for the
fiscal year in which the report is submitted and for
the other fiscal years within the applicable 5-year
budget plan relating to such fiscal year; and
''(B) a summary of the request of each National
Drug Control Program agency to the Director under this
Act (prior to review of the request by the Office of
Management and Budget) for the resources required to
achieve the targets of the agency under this Act;
''(14) act as a representative of the President before
Congress on all aspects of the National Drug Control Program;
''(15) act as the primary spokesperson of the President on
drug issues;
''(16) make recommendations to National Drug Control
Program agency heads with respect to implementation of Federal
counter-drug programs;
''(17) take such actions as necessary to oppose any attempt
to legalize the use of a substance (in any form) that--
''(A) is listed in schedule I of section 202 of the
Controlled Substances Act (21 U.S.C. 812); and
''(B) has not been approved for use for medical
purposes by the Food and Drug Administration; and
''(18) ensure that drug prevention and drug treatment
research and information is effectively disseminated by
National Drug Control Program agencies to State and local
governments and nongovernmental entities involved in demand
reduction by--
''(A) encouraging formal consultation between any
such agency that conducts or sponsors research, and any
such agency that disseminates information in developing
research and information product development agendas;
''(B) encouraging such agencies (as appropriate) to
develop and implement dissemination plans that
specifically target State and local governments and
nongovernmental entities involved in demand reduction;
and
''(C) developing a single interagency clearinghouse
for the dissemination of research and information by
such agencies to State and local governments and
nongovernmental agencies involved in demand
reduction.''.
(b) Survey of Drug Use.--
(1) In general.--The University of Michigan shall not be
prohibited under any law from conducting the survey of drug use
among young people in the United States known as the Monitoring
the Future Survey.
(2) Other surveys.--The National Parents' Resource
Institute for Drug Education in Atlanta, Georgia, shall not be
prohibited under any law from conducting the survey of drug use
among young people in the United States known as the National
PRIDE Survey.

SEC. 4. EXPANSION OF POWERS OF DIRECTOR.

Section 1003(d) (21 U.S.C. 1502(d)) is amended--
(1) in paragraph (9), by striking the period and inserting
a semicolon; and
(2) by adding at the end the following:
''(10) require the heads of National Drug Control Program
agencies to provide the Director with statistics, studies,
reports, and any other information regarding Federal control of
drug abuse;
''(11) require the heads of National Drug Control Program
agencies to provide the Director with information regarding any
position (before an individual is nominated for such position)
that--
''(A) relates to the National Drug Control Program;
''(B) is at or above the level of Deputy Assistant
Secretary; and
''(C) involves responsibility for Federal
counternarcotics or antidrug programs; and
''(12) make recommendations to the National Drug
Intelligence Center on the specific projects that the Director
determines will enhance the effectiveness of implementation of
the National Drug Control Strategy.''.

SEC. 5. SUBMISSION OF NATIONAL DRUG CONTROL STRATEGY.

(a) In General.--Section 1005(a) (21 U.S.C. 1504(a)) is amended--
(1) in paragraph (2)--
(A) by striking subparagraph (A) and inserting the
following:
''(A) include comprehensive, research-based, specific,
long-range goals and performance measures (including specific
annual targets expressed in terms of precise percentages) for
reducing drug abuse and the consequences of drug abuse in the
United States;'';
(B) in subparagraph (C), by striking ''and'' at the
end;
(C) by striking subparagraph (D);
(D) by adding at the end the following:
''(D) include 4-year projections for National Drug Control
Program priorities (including budget priorities); and
''(E) review international, Federal, State, local, and
private sector drug control activities to ensure that the
United States pursues well-coordinated and effective drug
control at all levels of government.'';
(2) in paragraph (3)(A), by striking clauses (iv) and (v)
and inserting the following:
''(iv) private citizens and organizations with experience
and expertise in demand reduction;
''(v) private citizens and organizations with experience
and expertise in supply reduction; and
''(vi) appropriate representatives of foreign
governments.'';
(3) in paragraph (4)--
(A) in subparagraph (B), by striking clauses (i)
through (vi) and inserting the following:
''(i) the quantities of cocaine, heroin, marijuana,
methamphetamine, ecstasy, and rohypnol available for
consumption in the United States;
''(ii) the amount of cocaine, heroin, marijuana,
ecstasy, rohypnol, methamphetamine, and precursor
chemicals entering the United States;
''(iii) the number of hectares of marijuana, poppy,
and coca cultivated and destroyed domestically and in
other countries;
''(iv) the number of metric tons of marijuana,
cocaine, heroin, and methamphetamine seized;
''(v) the number of cocaine and methamphetamine
processing labs destroyed domestically and in other
countries;
''(vi) changes in the price and purity of heroin
and cocaine, changes in price of methamphetamine, and
changes in tetrahydrocannabinol level of marijuana;'';
(B) in subparagraph (C), by striking ''and'' at the
end;
(C) in subparagraph (D), by striking the period at
the end and inserting ''; and''; and
(D) by adding at the end the following:
''(E) assessment of the cultivation of illegal drugs in the
United States.''; and
(4) in paragraph (5)--
(A) in the matter preceding subparagraph (A), by
striking ''February 1, 1995'' and inserting ''February
1, 1999'';
(B) in the matter preceding subparagraph (A), by
striking ''second'';
(C) in subparagraph (C), by striking ''and'' at the
end;
(D) in subparagraph (D), by striking the period at
the end and inserting ''; and''; and
(E) by adding at the end the following:
''(E) a description of the National Drug Control Program
performance measures described in subsection (a)(2)(A).''.
(b) Goals and Performance Measures for National Drug Control
Strategy.--Section 1005(b) (21 U.S.C. 1504(b)) is amended--
(1) in the heading, by striking '', Objectives, and
Priorities'' and inserting ''and Performance Measures'';
(2) in the matter after the heading, by inserting ''(1)''
before ''Each National Drug Control Strategy'';
(3) by redesignating paragraphs (1) through (6) as
subparagraphs (A) through (F), respectively;
(4) in subparagraph (A) (as redesignated by paragraph (3)),
by striking ''and priorities'' and inserting ''and performance
measures'';
(5) in subparagraph (C) (as redesignated by paragraph (3)),
by striking ''3-year projections'' and inserting ''4-year
projections''; and
(6) by adding at the end the following:
''(2) In establishing the performance measures required by this
subsection, the Director shall--
''(A) establish performance measures and targets expressed
in terms of precise percentages for each National Drug Control
Strategy goal and objective;
''(B) revise such performance measures and targets as
necessary, and reflect such performance measures and targets in
the National Drug Control Program budget submitted to Congress;
''(C) consult with affected National Drug Control Program
agencies;
''(D) identify programs and activities of National Drug
Control Program agencies that support the goals of the National
Drug Control Strategy;
''(E) evaluate in detail the implementation by each
National Drug Control Program agency of program activities
supporting the National Drug Control Strategy;
''(F) monitor consistency between the drug-related goals of
the National Drug Control Program agencies and ensure that drug
control agency goals and budgets fully support, and are fully
consistent with, the National Drug Control Strategy;
''(G) coordinate the development and implementation of
national drug control data collection and reporting systems to
support Federal policy formulation and performance measurement;
''(H) ensure that no Federal drug control funds are
expended for any study or contract relating to the legalization
(for a medical use or any other use) of a substance listed in
schedule I of section 202 of the Controlled Substances Act (21
U.S.C. 812); and
''(I) ensure that no Federal funds appropriated for the
High Intensity Drug Trafficking Program are expended for the
expansion of drug treatment programs.''.

SEC. 6. REPORT ON DESIGNATION OF HIGH INTENSITY DRUG TRAFFICKING AREAS.

Section 1005(c)(3) (21 U.S.C. 1504(c)(3)) is amended to read as
follows:
''(3) Annual report.--Not later than March 1 of each year, the
Director shall submit to Congress a report--
''(A) on the effectiveness of, and need for, the
designation of areas under this subsection as high intensity
drug trafficking areas; and
''(B) that includes any recommendations of the Director for
legislative action with respect to such designation.''.

SEC. 7. EXTENSION OF AUTHORIZATION OF APPROPRIATIONS.

Section 1011 (21 U.S.C. 1508) is amended by striking ''8 succeeding
fiscal years'' and inserting ''10 succeeding fiscal years''.

SEC. 8. REPORT REQUIRED.

Not later than November 1, 1998, the Director of the Office of
National Drug Control Policy shall submit to Congress a report
including--
(1) proposed goals, targets, performance measures (as
described in section 1003(b)(1) of the National Narcotics
Leadership Act of 1988 (21 U.S.C. 1502(b)(1))), and specific
initiatives with respect to the National Drug Control Program,
including the High Intensity Drug Trafficking Area Program; and
(2) proposals to coordinate the efforts of all National
Drug Control Program agencies.

SEC. 9. CONSISTENCY WITH NATIONAL SECURITY ACT OF 1947.

Section 1004 (21 U.S.C. 1503) is amended--
(1) in subsection (a)--
(A) by striking ''(1)'';
(B) by striking ''(2)(A)'' and inserting ''(b)
Consistency With National Security Act of 1947.--(1)'';
(C) by striking ''(B)'' and inserting ''(2)''; and
(D) by striking ''subparagraph (A)'' and inserting
''paragraph (1)''; and
(2) by redesignating subsections (b) and (c) as subsections
(c) and (d), respectively.
Drug Czar Responsibility and Accountability Act of 1998 - Amends Federal law to expand the responsibilities of the Director of National Drug Control Policy to include: (1) establishing Federal policies, objectives, goals, priorities, and performance measures for the National Drug Control Program, and for each Program agency, which shall include targets for reducing the levels of overall unlawful drug use, adolescent unlawful drug use, and drug-related emergency room incidents to January 19, 1993 levels; (2) requiring the submission of specified reports from Program agencies; (3) making recommendations to Program agency heads on the implementation of Federal counter-drug programs; (4) taking actions to oppose any attempt to legalize the use of a substance in any form that is listed in Schedule I of the Controlled Substances Act and that has not been approved for medical use by the Food and Drug Administration; and (5) ensuring that drug prevention and drug treatment research and information is effectively disseminated by Program agencies to State and local governments and nongovernmental entities involved in demand reduction.
States that certain surveys of drug use among young people in the United States shall not be prohibited under any law.
(Sec. 4) Expands the powers of the Director, to include: (1) requiring the heads of Program agencies to provide the Director with statistics, studies, reports, and any other information regarding Federal control of drug abuse; and (2) making recommendations to the National Drug Control Center on the specific projects that the Director determines will enhance the effectiveness of the National Drug Control Strategy.
(Sec. 5) Revises National Drug Control Strategy requirements to include: (1) comprehensive, research-based, specific, long-range goals and performance measures (including specific annual targets expressed in terms of precise percentages) for reducing drug abuse and the consequences of drug abuse in the United States; (2) four-year projections for Program priorities, including budget priorities; and (3) the review of international, Federal, and private sector drug control activities (currently, State and local drug control activities).
Revises requirements for the assessment of the reduction of drug availability by certain measurements.
Sets forth requirements with respect to the establishment of performance measures by the Director.
(Sec. 7) Extends the authorization of appropriations for the Office of Drug Control Policy until September 30, 1999.
(Sec. 8) Directs the Director to submit a report to the Congress including: (1) proposed goals, targets, performance measures and specific initiatives with respect to the Program, including the High Intensity Drug Trafficking Area Program; and (2) proposals to coordinate the efforts of all Program agencies.